Robert Iannone - 09 Dec 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP, Global Head of R&D
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Issuer symbol
JAZZ
Transactions as of
09 Dec 2022
Net transactions value
-$279,440
Form type
4
Filing time
13 Dec 2022, 16:16:32 UTC
Previous filing
28 Jun 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale $279,440 -1,844 -4.8% $151.54 36,316 09 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022.